To deliver deeper qualitative research insights at speed, Inizio Engage combined AI-driven analysis with expert validation, cutting turnaround time by 70% while capturing strategic nuances that automation alone would have missed.
Scaling qualitative research across global pharmaceutical markets
A global pharmaceutical company sought to define the critical skills and capabilities required to strengthen sales and marketing teams across diverse markets, laying the foundation for sustained portfolio commercialization in a specific therapeutic indication over the coming years.
This required surfacing nuanced themes, behaviors, and functional differences across roles. The scale and complexity of the qualitative data, paired with tight timelines and cost constraints, presented a significant challenge for the client. Traditional methods would have demanded more time and strained internal resources, potentially compromising the depth or breadth of insights. The client asked Inizio Engage to find a faster, more scalable approach to ensure high-quality outputs without sacrificing rigor.
Combining AI-powered qualitative analysis with human expertise
Inizio Engage led a focused discovery phase to define the capabilities needed to strengthen sales and marketing teams. This included:
- 30+ in-depth stakeholder interviews, guided by a carefully crafted discussion guide.
- A targeted quantitative survey.
- A cross-functional steering committee to help surface critical perspectives early on, and ensure stakeholder alignment and engagement.
To accelerate data analysis and maintain quality, we employed our proprietary AI-enabled workflow to rapidly process the qualitative interview data, surfacing a list of the core skills and capability themes, and highlighting differences by function.
The use of AI enabled Inizio Engage to complete initial analysis and reporting within two days, compared to the standard one-week turnaround. Without it, delays would have disrupted follow-on workstreams and project milestones. Moreover, AI helped maintain project scale, avoiding compromises on the number of interviews and the depth of qualitative exploration.
Crucially, our hybrid model combined AI-driven efficiency with the strategic insight of our expert team. While AI surfaced the dominant themes and behaviors, it was our skilled specialists that provided the deep interpretation of responses that revealed subtle nuances, and the valuable insights that were pivotal for tailoring capability frameworks by role and market. This blend of technology and expertise ensured both speed and substance, empowering the client with clear, actionable insight to guide future commercialization strategies.
70% faster insights to support pharmaceutical commercialization
The project demonstrated that while AI can enhance the speed and scale of qualitative research, it is the combination with expert human oversight that unlocks true strategic value, which is foundational to Intelligent Commercialization™. The Inizio Engage team:
- Delivered full analysis in two days, a 70% faster turnaround than standard.
- Preserved interview volume and depth despite budget constraints, thanks to AI efficiency.
- Identified function-specific insights and behavioral nuances missed by AI alone.
- Validated core capabilities with layered expert moderation to ensure strategic relevance.
- Enabled fast, high-quality decision-making that shaped future portfolio commercialization initiatives.
Accelerate your pharma commercialization strategy
By combining AI-powered analysis with expert human insight, Inizio delivered faster, deeper qualitative research that translated complex findings into actionable commercial direction.
This is the essence of our approach to Intelligent Commercialization™ – using technology, expertise, and strategic insight to help pharma teams make smarter decisions and drive greater commercial impact.
Get in touch to discover how we can accelerate insight and strengthen your commercialization strategy.